Insulin loaded nanoparticle carrier system for oral administration. The nanoparticle carrier system will protect the insulin from enzyme digestion and conjugated ligands to the nanoparticle surface will provide a mechanism by which the loaded particles can be ‘taken’ across the intestinal epithelium. Once across the intestinal wall, the particles will enter systemic circulation and provide a steady release of insulin into the bloodstream. The purpose of the steady release is to maintain basal insulin levels for patients with Type I Diabetes. |
